Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Applied Motion Products introduces TSM14POE StepSERVO integrated motor August 21, 2019 Oil India, IOCL to relinquish Yemen block due to deteriorating political situation September 12, 2017 How IIoT Enhances Industrial Control Systems and SCADA January 9, 2020
Oil India, IOCL to relinquish Yemen block due to deteriorating political situation September 12, 2017